NCT00333684View on ClinicalTrials.gov

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

May 31, 2010

Conditions
Human Immunodeficiency VirusFacial Lipoatrophy
Interventions
DEVICE

BIO-ALCAMID SOFT TISSUE ENDOPROSTHESIS

prosthetic bioalcamid was injected- amounts determined by the plastic surgeon and depended individual needs

Trial Locations (1)

M5B 1L6

Maple Leaf Medical Clinic, Toronto

All Listed Sponsors
collaborator

Pur Medical Corporation

UNKNOWN

lead

Canadian Immunodeficiency Research Collaborative

OTHER

NCT00333684 - Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid | Biotech Hunter | Biotech Hunter